Edition:
United States

Ajanta Pharma Ltd (AJPH.NS)

AJPH.NS on National Stock Exchange of India

1,676.80INR
23 May 2017
Change (% chg)

-- (--)
Prev Close
Rs1,676.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
189,597
52-wk High
Rs2,125.00
52-wk Low
Rs1,399.30

Latest Key Developments (Source: Significant Developments)

Ajanta Pharma March-qtr consol profit rises
Wednesday, 3 May 2017 05:17am EDT 

May 3 (Reuters) - Ajanta Pharma Ltd :March quarter consol net profit 1.14 billion rupees versus profit 1.09 billion rupees year ago.March quarter consol total income 4.79 billion rupees versus 4.36 billion rupees year ago.Approved dividend of 7 rupees per share.  Full Article

Ajanta Pharma's Dahej facility does not get form 483 after FDA inspection
Monday, 10 Apr 2017 12:41am EDT 

Ajanta Pharma Ltd :Ajanta Pharma Ltd says co's Dahej facility was inspected by FDA from April 3-7, 2017; no form 483 was issued.  Full Article

Ajanta Pharma's Paithan facility been issued one procedural related 483 by USFDA
Thursday, 9 Feb 2017 12:02am EST 

Ajanta Pharma Ltd : Says company's Paithan facility was recently inspected by US FDA and company has issued one procedural related 483. . Says company has issued one procedural related 483 .Says is in process of responding to same within stipulated time prescribed by US FDA..  Full Article

Ajanta Pharma says no import alert by US FDA on co's facility
Tuesday, 24 Jan 2017 04:13am EST 

Ajanta Pharma Ltd : Ajanta Pharma Ltd says intend to clarify that there is no import alert by US FDA on our facility or any of our products approved by US FDA. . Ajanta Pharma Ltd says us authorities have seized product as it is not approved by US FDA . Ajanta Pharma - appears that unknown and unrelated entity/individual has sent some sildenafil manufactured by co sold in India or other emerging market to USA .Ajanta Pharma Ltd says have no relations or connection to this dispatch of sildenafil to USA.  Full Article

Ajanta Pharma gets USFDA nod for Duloxetine Hydrochloride delayed release capsules
Monday, 9 Jan 2017 05:09am EST 

Ajanta Pharma Ltd : Says Ajanta Pharma announces US FDA approval for Duloxetine Hydrochloride delayed release capsules .Says company will be launching the product shortly in 3 strengths, 20 mg, 30 mg and 60 mg strengths capsules.  Full Article

Ajanta Pharma gets US FDA approval for Omeprazole and Sodium Bicarbonate Powder
Friday, 29 Jul 2016 01:04am EDT 

Ajanta Pharma Ltd : Ajanta Pharma announces US FDA approval for Omeprazole and Sodium Bicarbonate Powder for Oral Suspension .  Full Article

Ajanta Pharma gets US FDA approval for launch of Omeprazole and Sodium bicarbonate capsules in U.S.
Monday, 18 Jul 2016 03:03am EDT 

Ajanta Pharma Ltd : Ajanta Pharma announces US FDA approval & launch of Omeprazole and Sodium Bicarbonate capsules in US market .  Full Article

Ajanta Pharma announces launch of memantine hydrochloride tablets in US
Tuesday, 14 Jun 2016 01:44am EDT 

Ajanta Pharma Ltd : Launch of memantine hydrochloride tablets in US .  Full Article

Ajanta Pharma gets USFDA approval for voriconazole tablets
Thursday, 26 May 2016 12:22am EDT 

Ajanta Pharma Ltd : Ajanta Pharma announces US FDA approval of voriconazole tablets .  Full Article

Ajanta Pharma Ltd gets approvals for 3 ANDA's
Tuesday, 4 Aug 2015 03:03am EDT 

Ajanta Pharma Ltd:Ajanta Pharma gets approvals for 3 ANDAs.US FDA approves andas for 3 Montekulast products.Co intends to launch these products shortly.  Full Article

More From Around the Web

BRIEF-Ajanta Pharma March-qtr consol profit rises

* March quarter consol net profit 1.14 billion rupees versus profit 1.09 billion rupees year ago